Charles Morgan Kendrick Jr. - 02 Mar 2026 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role: EVP & President, Commercial
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol: ELV
Transactions as of: 02 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 04 Mar 2026, 16:58:09 UTC
Previous filing: 05 Mar 2025
Next filing: 09 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kendrick Charles Morgan JR	EVP & President, Commercial	220 VIRGINIA AVE, INDIANAPOLIS	/s/ Kathleen S. Kiefer, Attorney in fact	04 Mar 2026	0001887908

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELV	Common Stock	Tax liability		-1,211	-12%	$294.07^*	8,905	02 Mar 2026	Direct	F1
transaction	ELV	Common Stock	Award		+4,017	+45%	$0.000000^*	12,922	02 Mar 2026	Direct	F2
transaction	ELV	Common Stock	Award		+2,532	+20%	$0.000000^*	15,454	02 Mar 2026	Direct	F3
transaction	ELV	Common Stock	Tax liability		-467	-3%	$284.03^*	14,987	03 Mar 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELV	Employee Stock Option (Right to Buy)	Award		+15,870		$0.000000^*	15,870	02 Mar 2026	Common Stock	15,870	$294.07	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2	Represents restricted share units. Restrictions lapse as follows: 1,339 shares on 3/2/2027, 3/2/2028 and 3/2/2029.
F3	Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.
F4	The option represents a right to purchase a total of 15,870 shares, and is exercisable in three annual installments, each installment of 5,290 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.